Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) FCF Margin (2020 - 2025)

IDEAYA Biosciences (IDYA) has disclosed FCF Margin for 6 consecutive years, with 835.13% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 91854.0% to 835.13% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 33.59% through Dec 2025, up 355842.0% year-over-year, with the annual reading at 33.59% for FY2025, 355842.0% up from the prior year.
  • FCF Margin hit 835.13% in Q4 2025 for IDEAYA Biosciences, down from 68.41% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 68.41% in Q3 2025 to a low of 1753.67% in Q4 2024.
  • Historically, FCF Margin has averaged 474.37% across 5 years, with a median of 363.86% in 2023.
  • Biggest five-year swings in FCF Margin: plummeted -114935bps in 2021 and later surged 91854bps in 2025.
  • Year by year, FCF Margin stood at 582.78% in 2021, then rose by 0bps to 581.05% in 2022, then decreased by -5bps to 609.26% in 2023, then plummeted by -188bps to 1753.67% in 2024, then soared by 52bps to 835.13% in 2025.
  • Business Quant data shows FCF Margin for IDYA at 835.13% in Q4 2025, 68.41% in Q3 2025, and 1753.67% in Q4 2024.